Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 37Terminated 12Unknown 6Recruiting 4Withdrawn 3

Sponsor Class

INDUSTRY 2OTHER 1NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

relugolix 1Uterine Myomectomy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Menorrhagia × Clear all
NCT07378098 2026-05-01

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

JW Pharmaceutical

Phase 3 Recruiting
254 enrolled

Leiomyoma, Menorrhagia

NCT06692335 2026-03-27

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

Chinese University of Hong Kong

Phase NA Recruiting
112 enrolled

Dysmenorrhea, Leiomyoma, Menorrhagia

NCT07397715 2026-02-12

MUSA3

Swiss GO Trial Group

Recruiting
1,000 enrolled
Gynecologic

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
120 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡